Select Publications
Journal articles
2024, 'Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.126418
,2024, 'Author Correction: Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia (Scientific Reports, (2022), 12, 1, (332), 10.1038/s41598-021-04080-3)', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-52791-0
,2024, 'Modelling respiratory syncytial virus age-specific risk of hospitalisation in term and preterm infants', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-09400-2
,2024, 'Modelling the impact of hybrid immunity on future COVID-19 epidemic waves', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-09282-4
,2024, 'Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study', The Lancet Global Health, 12, pp. e1764 - e1774, http://dx.doi.org/10.1016/S2214-109X(24)00286-9
,2024, 'Corrigendum to “Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024” [Vaccine 42(15) (2024) 3379–3383, (S0264410X24004948), (10.1016/j.vaccine.2024.04.057)]', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.07.003
,2024, 'Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned', The Lancet Respiratory Medicine, 12, pp. 663 - 664, http://dx.doi.org/10.1016/S2213-2600(24)00214-5
,2024, 'Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February–1 March 2024', Vaccine, 42, pp. 3379 - 3383, http://dx.doi.org/10.1016/j.vaccine.2024.04.057
,2024, 'Report from the World Health Organization's immunization and vaccines related implementation research advisory committee (IVIR-AC) meeting, Geneva, 11–13 September 2023', Vaccine, 42, pp. 1424 - 1434, http://dx.doi.org/10.1016/j.vaccine.2024.02.014
,2024, 'Baby in tow', Science, 383, pp. 562, http://dx.doi.org/10.1126/science.ado3078
,2023, 'Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach', Nature Communications, 14, pp. 4325, http://dx.doi.org/10.1038/s41467-023-39736-3
,2023, 'Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa', Influenza and other Respiratory Viruses, 17, pp. e13229, http://dx.doi.org/10.1111/irv.13229
,2023, 'Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study', PLoS Medicine, 20, pp. e1004195, http://dx.doi.org/10.1371/journal.pmed.1004195
,2023, 'Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study', The Lancet Public Health, 8, pp. e174 - e183, http://dx.doi.org/10.1016/S2468-2667(22)00337-1
,2022, 'Developing a prediction model to estimate the true burden of respiratory syncytial virus (RSV) in hospitalised children in Western Australia', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-021-04080-3
,2022, 'Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic', Communications Medicine, 2, http://dx.doi.org/10.1038/s43856-022-00075-x
,2022, 'Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study', The Lancet Global Health, 10, pp. e1782 - e1792, http://dx.doi.org/10.1016/S2214-109X(22)00416-8
,2022, 'Global impact of the first year of COVID-19 vaccination: a mathematical modelling study', The Lancet Infectious Diseases, 22, pp. 1293 - 1302, http://dx.doi.org/10.1016/S1473-3099(22)00320-6
,2022, 'Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS', Nature Computational Science, 2, pp. 223 - 233, http://dx.doi.org/10.1038/s43588-022-00233-0
,2021, 'Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage', Malaria Journal, 20, http://dx.doi.org/10.1186/s12936-021-03966-x
,2021, 'Health inequities and clustering of fever, acute respiratory infection, diarrhoea and wasting in children under five in low- and middle-income countries: a Demographic and Health Surveys analysis', BMC Medicine, 19, http://dx.doi.org/10.1186/s12916-021-02018-0
,2021, 'A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks', Applied Health Economics and Health Policy, 19, pp. 673 - 697, http://dx.doi.org/10.1007/s40258-021-00659-z
,2021, 'Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand', Vaccine, 39, pp. 4383 - 4390, http://dx.doi.org/10.1016/j.vaccine.2021.05.100
,2021, 'Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis', Vaccine, 39, pp. 2995 - 3006, http://dx.doi.org/10.1016/j.vaccine.2021.04.002
,2021, 'Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review', , http://dx.doi.org/10.12688/wellcomeopenres.16992.1
,2020, 'Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting', BMC Medicine, 18, http://dx.doi.org/10.1186/s12916-020-01783-8
,2020, 'Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study', PLoS Medicine, 17, http://dx.doi.org/10.1371/JOURNAL.PMED.1003377
,2020, 'Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination', Vaccine, 38, pp. 7498 - 7507, http://dx.doi.org/10.1016/j.vaccine.2020.09.069
,2020, 'Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study', The Lancet Global Health, 8, pp. e1132 - e1141, http://dx.doi.org/10.1016/S2214-109X(20)30288-6
,2020, 'The potential public health consequences of COVID-19 on malaria in Africa', Nature Medicine, 26, pp. 1411 - 1416, http://dx.doi.org/10.1038/s41591-020-1025-y
,2018, 'Modelling population-level impact to inform target product profiles for childhood malaria vaccines', BMC Medicine, 16, http://dx.doi.org/10.1186/s12916-018-1095-6
,2017, 'Potential impact of a maternal vaccine for RSV: A mathematical modelling study', Vaccine, 35, pp. 6172 - 6179, http://dx.doi.org/10.1016/j.vaccine.2017.09.043
,2017, 'Complex demodulation: a novel time series method for analysing seasonal infectious diseases', ANZIAM Journal, 59, pp. 51 - 51, http://dx.doi.org/10.21914/anziamj.v59i0.10894
,2017, 'COMPLEX DEMODULATION: A NOVEL TIME SERIES METHOD for ANALYSING SEASONAL INFECTIOUS DISEASES', ANZIAM Journal, 59, pp. 51 - 60, http://dx.doi.org/10.1017/S1446181116000377
,2017, 'A Model for the Spread of an Invasive Weed, Tradescantia fluminensis', Bulletin of Mathematical Biology, 79, pp. 1201 - 1217, http://dx.doi.org/10.1007/s11538-017-0280-7
,2017, 'Unexpected infection spikes in a model of respiratory syncytial virus vaccination', Vaccines, 5, http://dx.doi.org/10.3390/vaccines5020012
,2016, 'Time series analysis of RSV and bronchiolitis seasonality in temperate and tropical Western Australia', Epidemics, 16, pp. 49 - 55, http://dx.doi.org/10.1016/j.epidem.2016.05.001
,2016, 'Exploring the dynamics of respiratory syncytial virus (RSV) transmission in children', Theoretical Population Biology, 110, pp. 78 - 85, http://dx.doi.org/10.1016/j.tpb.2016.04.003
,2014, 'Modelling the seasonal epidemics of respiratory syncytial virus in young children', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0100422
,